Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Phase I trial initiated for HER-2 vaccine for breast cancer

Oct. 16, 2002

M-Vax and O-Vax INDs cleared

Oct. 15, 2002

Enrollment completed in phase II Theratope trial for metastatic colorectal cancer

Oct. 14, 2002

Genentech returns rights to SGN-14 to Seattle Genetics

Oct. 10, 2002

NCI awards SPORE grant for lymphoma research

Oct. 7, 2002

New modulators of immunotherapeutic agents described by Altachem and U. of Alberta

Oct. 7, 2002

Igeneon licenses IGN-301 from Novartis

Oct. 4, 2002

Avax signs distribution agreement with Ferrer for AC Vaccine technology

Oct. 4, 2002

Potential use of the HSPPC-96 vaccine in patients with metastatic renal cell carcinoma

Oct. 4, 2002

Allovectin-7 update

Oct. 1, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...